Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kristian Unger"'
Autor:
Lisa Kreutzer, Peter Weber, Theresa Heider, Mathias Heikenwälder, Tobias Riedl, Philipp Baumeister, Frederick Klauschen, Claus Belka, Axel Walch, Horst Zitzelsberger, Julia Hess, Kristian Unger
Publikováno v:
Lab. Invest. 102, 1400-1405 (2022)
Matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) allows spatial analysis of proteins, metabolites, or small molecules from tissue sections. Here, we present the simultaneous generation and analysis of MALDI-MSI, whole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba38a4ed4beb7e8d9caadeef84619fd7
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=66094
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=66094
Autor:
Peter Weber, Martin Selmansberger, Andreas Blutke, Horst Zitzelsberger, Elena Stauffer, Kristian Unger, Kirsten Lauber, Gerald Burgstaller, Claudia Dalke, Theresa Heider, Axel Walch, Nikko Brix
Publikováno v:
Endocr. Relat. Cancer 28, 213-224 (2021)
Thyroid carcinoma incidence rates in western societies are among the fastest rising, compared to all malignant tumors over the past two decades. While risk factors such as age and exposure to ionizing radiation are known, early-state carcinogenic pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbd55150e7df4833802f55529b56bf1
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=61493
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=61493
Autor:
Herbert Braselmann, Anne-Laure Boulesteix, Horst Zitzelsberger, Kristian Unger, Julia Hess, Roman Hornung, Claus Belka, Daniel Samaga
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-14 (2020)
Radiat. Oncol. 15:109 (2020)
Radiation Oncology, Vol 15, Iss 1, Pp 1-14 (2020)
Radiat. Oncol. 15:109 (2020)
Background Prognostic models based on high-dimensional omics data generated from clinical patient samples, such as tumor tissues or biopsies, are increasingly used for prognosis of radio-therapeutic success. The model development process requires two
Autor:
Frank Haubner, Julia Kitz, Stefan Küffer, Bernhard G. Weiss, Julia Hess, Friedrich Ihler, Kristian Unger, Martin Canis, Mark Jakob, Mattis Bertlich, Lena M. Mattes
Publikováno v:
HeadneckREFERENCES. 41(10)
Background MicroRNAs (miRNA) recently evolved as potential cancer biomarkers. Therefore, the aim of the present study was to evaluate the prognostic impact of eight miRNAs connected to oral squamous cell carcinoma (OSCC). Method Expression levels of
Autor:
Joachim P. Steinbach, Michel Mittelbronn, Kirsten Lauber, Claus Rödel, Adriana Pitea, Claus Belka, Maximilian Niyazi, Franz Zehentmayr, Carsten Sticht, D. Piehlmaier, Horst Zitzelsberger, Ute Ganswindt, Kristian Unger
Publikováno v:
Oncotarget
Oncotarget 7, 45764-45775 (2016)
Oncotarget 7, 45764-45775 (2016)
Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment outcome. Here, we examined whether a miRNA signature can be defined for the a priori identification of patients with particularly poor prognosis. FFPE
Autor:
Lars Schüttrumpf, Ute Ganswindt, Axel Walch, Adriana Pitea, Claus Belka, Cornelius Maihoefer, Martin Selmansberger, Horst Zitzelsberger, Philipp Baumeister, Christina Wilke, Thomas Kirchner, Ludmila Wintergerst, Julia Hess, Christine Woischke, Kristian Unger
Publikováno v:
Molecular Oncology
Mol. Oncol., DOI: 10.1002/1878-0261.12388 (2018)
Molecular Oncology, Vol 12, Iss 12, Pp 2085-2101 (2018)
Mol. Oncol., DOI: 10.1002/1878-0261.12388 (2018)
Molecular Oncology, Vol 12, Iss 12, Pp 2085-2101 (2018)
Previously, we have shown that copy number gain of the chromosomal band 16q24.3 is associated with impaired clinical outcome of radiotherapy-treated head and neck squamous cell carcinoma (HNSCC) patients. We set out to identify a prognostic mRNA sign
Autor:
T. Kirchner, L Schuettrumpf, Philipp Baumeister, Isolde Summerer, H. Zitzelsberger, Eva K. Sage, Maximilian Niyazi, Gabriele Multhoff, H. Braselmann, Cornelius Maihoefer, Hanno M. Specht, Kristian Unger, Simone Moertl, Claus Belka
Publikováno v:
Br. J. Cancer 113, 76-82 (2015)
British Journal of Cancer
British Journal of Cancer
Background: The prediction of therapy response in head and neck squamous cell cancer (HNSCC) requires biomarkers, which are also a prerequisite for personalised therapy concepts. The current study aimed to identify therapy-responsive microRNAs (miRNA
Autor:
Luca Mariotti, V. E. Bellinzona, Andrea Ottolenghi, Kristian Unger, Gabriele Babini, Jacopo Morini, Giorgio Baiocco
Publikováno v:
Radiation Protection Dosimetry. 166:165-169
The aim of the present work was to investigate the mechanisms of radiation-induced bystander signalling leading to apoptosis in non-irradiated co-cultured cells. Cultured non-transformed cells were irradiated, and the effect on the apoptosis rate on
Autor:
Verena Zangen, Martin Selmansberger, Guido A. Drexler, A. Michna, Sebastian Kuger, Julia Hess, Igor Gimenez-Aznar, Anna A. Friedl, Kristian Unger, Diana Klein, Ramona Stamp, Horst Zitzelsberger, Claus Belka, U. Schötz, Lars Schüttrumpf, Kirsten Lauber, Herbert Braselmann, Verena Jendrossek, Michael Orth, Ludmila Schneider, Ludwig Hieber
Publikováno v:
Cancer letters. 386
Radio (chemo) therapy is a crucial treatment modality for head and neck squamous cell carcinoma (HNSCC), but relapse is frequent, and the underlying mechanisms remain largely elusive. Therefore, novel biomarkers are urgently needed. Previously, we id
Autor:
Martin Selmansberger, Julia Hess, Kirsten Lauber, A. Michna, Kristian Unger, U. Schötz, Horst Zitzelsberger
Publikováno v:
Radiation Oncology (London, England)
Radiat. Oncol. 11:94 (2016)
Radiat. Oncol. 11:94 (2016)
Background Acquired and inherent radioresistance of tumor cells is related to tumor relapse and poor prognosis – not only in head and neck squamous cell carcinoma (HNSCC). The underlying molecular mechanisms are largely unknown. Therefore, systemic